Literature DB >> 1835585

Phase II studies: wrong doses, wrong patients?

I R Judson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1835585     DOI： 10.1016/0277-5379(91)90080-w

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life.

Authors:  C J Twelves; N A Dobbs; M A Lawrence; A J Ramirez; M Summerhayes; M A Richards; K E Towlson; R D Rubens
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.